Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
Inappropriate Schedule of Vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose of vaccine in May 2018) and Twinrix (received 2nd dose of vaccine in June 2018). On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: Inappropriate Schedule of Vaccine). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-JUL-2025 The pharmacist had called to report that a patient had been administered two doses of Twinrix back in May and June of Twenty-eighteen. It was unclear whether the vaccination series needed to be restarted, as no specific vaccination dates or vaccine details had been obtained during the call. Till the time of reporting, the patient did not receive 3rd dose of Twinrix, which led to incomplete course of vaccination.